Your Location：
Home >
Browse articles >
Shaoyaotang Containing Serum Mediates Fas/FasL Pathway to Inhibit Lipopolysaccharide Induced Inflammation and Apoptosis of Caco-2 Cells
Updated：2025-05-30
Previous|Next

    • Shaoyaotang Containing Serum Mediates Fas/FasL Pathway to Inhibit Lipopolysaccharide Induced Inflammation and Apoptosis of Caco-2 Cells

      Enhanced Publication
    • YANG Yuting , WU Dongsheng , CAO Hui , ZHANG Yu , XIE Nianjia , ZOU Bo , CHEN Daguang , LIU Erle , LU Yi , LYU Zhaowen
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 31, Issue 13, Pages: 62-69(2025)

    • DOI： 10.13422/j.cnki.syfjx.20250404     

      CLC：

    Scan QR Code

  •  
  •  

  • AI Introduction

  • Full Text(HTML)

  • Figs( 1 ) Tabs( 6 )

  • Editor's note

  • References

  • Publication Info

  • Metrics

348

Views

261

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Shaoyaotang Regulates TLR4/MyD88/NF-κB Signaling Pathway to Protect Intestinal Mucosal Barrier in Ulcerative Colitis
Shaoyaotang Regulates miRNA-155-mediated SOCS1/JAK1/STAT1 Signaling Pathway to Affect Macrophage Polarization
Shaoyaotang Ameliorates Ulcerative Colitis by Regulating miR-155-5p
Effect and Mechanisms of Shaoyaotang on Murine Ulcerative Colitis via Modulating Macrophage Glycolytic Reprogramming and Polarization Through HIF-1α Pathway
Shaoyaotang Restores Th17/Treg Cell Balance by Regulating Glucose Metabolism Reprogramming in Treatment of Ulcerative Colitis

Related Author

WU Dongsheng
ZHANG Yu
QUAN Wenjing
XIONG Wanqing
XIAO Youwei
HUANG Ruoru
GONG Yan
CAO Hui

Related Institution

Anhui University of Chinese Medicine
School of Life Sciences， Beijing University of Chinese Medicine
Dongzhimen Hospital， Beijing University of Chinese Medicine
Hunan University of Chinese Medicine
Nanjing Medical University